Pharma/Fine Chemicals Roundup – August 2

LONZA REPORTS FALL IN FIRST-HALF PROFITS AND SALES Lonza has recorded a 28% fall in first-half profits compared with the year-ago period, to SF97 million ($120 million), and Ebitda decreased by 14%, to SF265 million. Sales decreased 8%, to SF1.19 billion, mainly due to the negative currency exchange rate, Lonza says. “Despite the heavy hit we have taken in our reported numbers as a result of the strong Swiss franc, I am pleased that the company has delivered 5% growth in underlying revenues and operating profits,” says Stefan Borgas, CEO of Lonza...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers